22 research outputs found
Resting energy expenditure in morbid obesity
Resting energy expenditure (REE) was measured in 112 morbidly obese adults prior to elective gastric bypass surgery. The patients studied ranged from 157 to 327% of ideal body weight. Standard nutritional assessment indices (serum total protein, albumin, total iron binding capacity, hematocrit, and white blood cell count) were within normal limits. REE was estimated by the Harris-Benedict formula using both current weight and ideal weight. Measured REE was significantly less than expected (p < 0.01) using current weight and significantly greater than expected (p < 0.01) when ideal weight was used as the standard. Linear regression analysis between standard indices that reflect resting metabolic rate in normal adults and measured REE in study patients did not demonstrate sufficient correlation to be clinically useful in this patient population. Standard surgical therapy may result in highly variable weight loss in this population if the wide range of resting energy expenditure and the consequential variability in individual caloric deficits is not considered. Standard predictors do not identify those patients likely to be unsuccessful with a given weight loss regimen
Recommended from our members
Use of radiotracer for sentinel lymph node mapping in breast cancer optimizes staging independent of site of administration
Purpose: In an effort to optimize sentinel lymph node (SLN) mapping for breast cancer, sites of mapping agent administration and types of mapping agents used continue to be evaluated. This study compares SLN mapping using peritumoral (PT) or subareolar (SA) injection of radiolabeled colloid and examines the relative contributions of radiotracer and blue dye to SLN identification.
Materials and Methods: A retrospective review was performed of 456 patients with breast cancer and clinically negative axillae who underwent SLN mapping. Sequential groups of patients were injected with filtered Tc-99m SC, 326 peritumorally (group 1) and 130 subareolarly (group 2). All patients had intraoperative SA injection of 1% isosulfan blue dye.
Results: The SLN identification and isotope success rates were 97% and 96% in group 1 and 98% and 98% in group 2, respectively. Eighty-one patients (25%) in group 1 and 44 patients (34%) in group 2 had positive SLNs. Of these patients, 15% from group 1 and 14% from group 2 had only positive nodes detected by radiotracer, and 9 of these patients (6 from group I and 3 from group 2) had other nodes identified by both radiotracer and blue dye that were negative for metastases. Six percent of patients with positive SLNs were upstaged because of use of radiotracer.
Conclusions: PT and SA injection of radiotracer have comparable success rates for axillary SLN identification. Given that 15% of patients in group 1 and 14% in group 2 had only positive SLNs detected by radiotracer, independent of site of administration, radiotracer remains essential for optimizing breast SLN mapping